Teaching in the Department of medical laboratory technologies at the Faculty of Health and medical technologies within the Southern Technical University, Dr. Samar Kazem Youssef obtained the patent marked ((production of nanoantibodies against
They are abundantly and permanently present on the surfaces of B lymphocytes. Cancer receptor CD19
The patent is proved by the results of obtaining bacteria carrying the encoded gene for the production of antibodies, nanoparticles and confirmation by colony PCR technology
The identity of the produced protein (nanoparticles) has also been proven and identified from the rest of the proteins using enzyme-linked immunoassay
